Article

Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Theranostic Applications

2025-02-02

Abstract excerpt

(1) <h4>Background</h4> Somatostatin receptor 2 (SSTR2) is overexpressed in various tumors, including hepatocellular carcinoma (HCC), yet its role in tumorigenesis remains unclear. This study examines the roles of SSTR2 in the molecular pathology of HCC and explores its potential as a target for SSTR2-directed radiopharmaceuticals in this malignancy. (2) <h4>Methods</h4> SSTR2 expression was analyzed across 22 m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f83b3926-3b99-5540-8c28-864312cd5f2d
DOI: 10.1101/2025.01.29.635283

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Theranostic ApplicationsDOI 10.1101/2025.01.29.635283Read

A pan-cancer analysis of the clinical and genetic portraits of somatostatin receptor expressing-tumor as a potential target of peptide receptor imaging and therapySemantic proximity Read

Somatostatin Receptor Based Imaging and Radionuclide TherapySemantic proximity Read

Somatostatin receptor 2 signaling promotes growth and tumor survival in small‐cell lung cancerSemantic proximity Read

Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.Semantic proximity Read

Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2–Platelet‐Derived Growth Factor Receptor Beta–Yes‐Associated Protein Signaling AxisSemantic proximity Read

FGFR2 Inhibition in Cholangiocarcinoma.Semantic proximity Read

Upregulation of Somatostatin Receptor Type 2 in a Receptor-Deficient <i>In Vivo</i> Pancreatic Neuroendocrine Tumor Model Improves Tumor Response to Targeted <sup>177</sup> Lu-DOTATATESemantic proximity Read

Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse.Semantic proximity Read

Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome.Semantic proximity Read

Characterization of Somatostatin Receptor 2 Gene Expression and Immune Landscape in Sinonasal MalignanciesSemantic proximity Read

Multiple Epigenetic Mechanisms Functionally Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine TumorsSemantic proximity Read

The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells.Semantic proximity Read